Illustration of an isotope emitting particles along glowing orbital paths

Radiopharmaceutical consultancy

Turning complex radiochemistry into clinical reality.

Radiopharmium is a specialist radiopharmaceutical consultancy. We work on tracer design and radiolabelling chemistry, GMP process development, and the transfer of methods into clinical production. Our clients are companies building a radiopharmaceutical capability, facilities bringing a new tracer into routine use, and investors who need the science checked before they commit.

Find out more Start a conversation

Specialist support across every stage of development.

From early research and preclinical studies through to CMC activities that support technology transfer and clinical translation.

Illustration of a laboratory flask on a stand

Research & Development

Tracer design, radiolabelling route selection and preclinical evaluation, across a range of isotopes including but not limited to F-18, Ga-68, Zr-89, Lu-177, Tb-161, Ac-225, Pb-212, Cu-64, Cu-67, 124-I, 123-I.

Illustration of an atom with orbiting electrons

CMC

Process development and automation on commercial synthesis platforms, specification setting, stability work and the CMC content of an IMPD.

Illustration of a GMP production machine

Clinical Translation & GMP

Method transfer into a licensed facility, process validation, QC method development and release testing.

Programme Strategy

An honest assessment of whether a route is manufacturable, what it will take to get it there, and advisory support on facility builds for research or GMP manufacture.

Illustration of a research team working around a large atom

For companies & startups

Senior scientific leadership, without a full-time hire.

We join your Scientific Advisory Board or step in through our fractional CSO model, setting R&D strategy, driving innovation, keeping compliance on track and delivering the milestones your investors expect.

Explore consultancy

For funders & investors

Independent due diligence in a complex field.

We assess the strengths, risks and opportunities of potential investments, bridging innovation and clinical application so you can be confident portfolio companies are built on sound science and realistic development pathways.

Explore due diligence